| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
50,227 |
21,754 |
$995K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,639 |
20,932 |
$768K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
9,579 |
9,473 |
$561K |
| 99223 |
Prolong inpt eval add15 m |
6,692 |
6,529 |
$397K |
| 99215 |
Prolong outpt/office vis |
2,896 |
2,810 |
$130K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
6,400 |
3,555 |
$106K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,773 |
2,669 |
$97K |
| 90961 |
|
1,337 |
1,328 |
$71K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
397 |
328 |
$56K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,414 |
1,372 |
$36K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
2,431 |
1,531 |
$26K |
| 99233 |
Prolong inpt eval add15 m |
533 |
279 |
$15K |
| 99205 |
Prolong outpt/office vis |
130 |
130 |
$11K |
| J0485 |
Injection, belatacept, 1 mg |
23 |
12 |
$7K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
58 |
43 |
$6K |
| 99442 |
|
325 |
315 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
571 |
465 |
$3K |
| 90962 |
|
47 |
46 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
76 |
67 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
79 |
79 |
$1K |
| 83970 |
|
50 |
50 |
$999.45 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$705.94 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
49 |
49 |
$689.49 |
| 85018 |
|
840 |
690 |
$474.27 |
| 99221 |
|
16 |
16 |
$465.16 |
| 36556 |
|
14 |
13 |
$320.30 |
| 93050 |
|
40 |
39 |
$252.10 |
| 76775 |
|
12 |
12 |
$245.30 |
| 93701 |
|
28 |
28 |
$235.38 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
57 |
55 |
$199.21 |
| 83735 |
|
45 |
44 |
$168.19 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$155.72 |
| 80051 |
|
120 |
111 |
$153.50 |
| 82570 |
|
60 |
57 |
$114.22 |
| 82310 |
|
120 |
111 |
$100.96 |
| 82565 |
|
120 |
111 |
$97.19 |
| 84100 |
|
121 |
112 |
$88.69 |
| ATP08 |
|
28 |
27 |
$87.30 |
| 82728 |
|
15 |
15 |
$86.38 |
| 84520 |
|
120 |
111 |
$69.24 |
| 84156 |
|
34 |
33 |
$58.45 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
19 |
19 |
$56.61 |
| 83550 |
|
14 |
14 |
$55.44 |
| ATP14 |
|
16 |
16 |
$54.45 |
| 36415 |
Collection of venous blood by venipuncture |
124 |
112 |
$51.02 |
| 82040 |
|
54 |
53 |
$44.46 |
| 83540 |
|
15 |
15 |
$41.02 |
| 84460 |
|
24 |
24 |
$39.78 |
| ATP09 |
|
15 |
14 |
$35.84 |
| 82043 |
|
17 |
17 |
$29.31 |
| 36416 |
|
94 |
77 |
$28.03 |
| 84550 |
|
30 |
30 |
$25.90 |
| 84450 |
|
24 |
24 |
$23.51 |
| 84075 |
|
24 |
24 |
$22.26 |
| 81001 |
|
21 |
21 |
$21.67 |
| 82247 |
|
24 |
24 |
$21.53 |
| 80061 |
Lipid panel |
13 |
13 |
$5.12 |
| 82550 |
|
13 |
13 |
$3.52 |
| 82947 |
|
15 |
15 |
$2.12 |